Birgit Willinger

4.6k total citations
123 papers, 2.7k citations indexed

About

Birgit Willinger is a scholar working on Infectious Diseases, Epidemiology and Cell Biology. According to data from OpenAlex, Birgit Willinger has authored 123 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 77 papers in Infectious Diseases, 68 papers in Epidemiology and 21 papers in Cell Biology. Recurrent topics in Birgit Willinger's work include Antifungal resistance and susceptibility (75 papers), Fungal Infections and Studies (49 papers) and Plant Pathogens and Fungal Diseases (21 papers). Birgit Willinger is often cited by papers focused on Antifungal resistance and susceptibility (75 papers), Fungal Infections and Studies (49 papers) and Plant Pathogens and Fungal Diseases (21 papers). Birgit Willinger collaborates with scholars based in Austria, Germany and United States. Birgit Willinger's co-authors include Alexander M. Hirschl, M. Rotter, Brigitte Selitsch, M. Manafi, Athanasios Makristathis, Elisabeth Presterl, Cornelia Lass‐Flörl, Christoph Steininger, Petra Apfalter and Claudia Schabereiter‐Gurtner and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Applied and Environmental Microbiology.

In The Last Decade

Birgit Willinger

118 papers receiving 2.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Birgit Willinger Austria 30 1.8k 1.7k 383 274 264 123 2.7k
Charalampos Antachopoulos Greece 28 1.3k 0.7× 1.3k 0.8× 189 0.5× 260 0.9× 243 0.9× 79 2.4k
Françoise Botterel France 34 2.4k 1.3× 2.0k 1.2× 445 1.2× 302 1.1× 333 1.3× 161 3.6k
Alain Bonnin France 30 1.9k 1.0× 1.3k 0.8× 241 0.6× 252 0.9× 206 0.8× 86 2.9k
Silke Schelenz United Kingdom 28 2.1k 1.2× 1.6k 0.9× 189 0.5× 312 1.1× 111 0.4× 75 2.9k
R. Grillot France 26 1.6k 0.9× 1.2k 0.7× 368 1.0× 192 0.7× 176 0.7× 77 2.2k
Robert W. Bradsher United States 29 2.6k 1.4× 2.9k 1.8× 414 1.1× 234 0.9× 595 2.3× 85 3.8k
Thomas M. Kerkering United States 25 2.0k 1.1× 1.9k 1.2× 297 0.8× 207 0.8× 210 0.8× 56 2.9k
Marie‐Elisabeth Bougnoux France 26 1.8k 1.0× 1.5k 0.9× 280 0.7× 402 1.5× 147 0.6× 67 2.4k
Michél Laverdière Canada 34 3.3k 1.8× 2.9k 1.7× 317 0.8× 261 1.0× 392 1.5× 103 4.4k
Dionysios Neofytos Switzerland 30 3.4k 1.9× 3.2k 2.0× 241 0.6× 296 1.1× 277 1.0× 120 4.5k

Countries citing papers authored by Birgit Willinger

Since Specialization
Citations

This map shows the geographic impact of Birgit Willinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Birgit Willinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Birgit Willinger more than expected).

Fields of papers citing papers by Birgit Willinger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Birgit Willinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Birgit Willinger. The network helps show where Birgit Willinger may publish in the future.

Co-authorship network of co-authors of Birgit Willinger

This figure shows the co-authorship network connecting the top 25 collaborators of Birgit Willinger. A scholar is included among the top collaborators of Birgit Willinger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Birgit Willinger. Birgit Willinger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Suchomel, Miranda, et al.. (2025). In vitro long-term exposure to chlorhexidine or triclosan induces cross-resistance against azoles in Nakaseomyces glabratus. Antimicrobial Resistance and Infection Control. 14(1). 2–2. 2 indexed citations
2.
Lötsch, Felix, Konstantin Doberer, Martina Scharitzer, et al.. (2025). Disseminated infection with Candida dubliniensis after ravulizumab and treatment with rezafungin – a case report. Journal de Mycologie Médicale. 35(2). 101545–101545. 1 indexed citations
3.
Selitsch, Brigitte, Barbara Steinlechner, Johannes Weber, et al.. (2024). Is the T2MR Candida Panel a suitable alternative to the SeptiFast for the rapid diagnosis of candidemia in routine clinical practice?. Clinical Microbiology and Infection. 30(6). 816–821. 5 indexed citations
4.
Chromy, David, A. N. Okoro, Katharina Grabmeier‐Pfistershammer, et al.. (2024). Asymptomatic lymphogranuloma venereum is commonly found among men who have sex with men in Austria. JDDG Journal der Deutschen Dermatologischen Gesellschaft. 22(3). 389–397. 3 indexed citations
5.
Chromy, David, Alexander Indra, Patrick Hyden, et al.. (2024). Genotypic cluster analysis of Neisseria gonorrhoeae reveals a spectrum of sexual mixing including among HIV-serodiscordant men who have sex with men. Infectious Diseases. 56(9). 712–721.
6.
Salmanton‐García, Jon, Martin Hoenigl, Helmut J.F. Salzer, et al.. (2023). The Austrian landscape of diagnostic capacity and access to treatment for invasive fungal infections. Mycoses. 66(12). 1056–1063. 7 indexed citations
7.
Wu, Christine C., Stefan Schmid, Brigitte Selitsch, et al.. (2023). Candida auris in Austria—What Is New and What Is Different. Journal of Fungi. 9(2). 129–129. 11 indexed citations
8.
Geusau, Alexandra, David Chromy, Claudia Eder, et al.. (2022). Resistance profiles of Neisseria gonorrhoeae isolates in Vienna, Austria: a phenotypic and genetic characterization from 2013 to 2020. International Journal of Antimicrobial Agents. 60(5-6). 106656–106656. 6 indexed citations
9.
Szépfalusi, Zsolt, Florian Götzinger, Birgit Willinger, et al.. (2021). Lessons from low seroprevalence of SARS‐CoV‐2 antibodies in schoolchildren: A cross‐sectional study. Pediatric Allergy and Immunology. 32(4). 762–770. 24 indexed citations
10.
Groll, Andreas H., Dieter Buchheidt, Birgit Willinger, et al.. (2021). State of Medical Mycology at German Academic Medical Centres: A Survey of the German‐Speaking Mycological Society (DMYKG) and the Paul‐Ehrlich‐Society for Chemotherapy (PEG). Mycoses. 64(10). 1177–1182. 1 indexed citations
11.
Koller, Walter, et al.. (2019). Augmenting Analytics Software for Clinical Microbiology by Man-Machine Interaction. Studies in health technology and informatics. 264. 1243–1247. 1 indexed citations
12.
Lass‐Flörl, Cornelia, Giuliana Lo Cascio, Márcio Nucci, et al.. (2019). Respiratory specimens and the diagnostic accuracy of Aspergillus lateral flow assays (LFA-IMMY™): real-life data from a multicentre study. Clinical Microbiology and Infection. 25(12). 1563.e1–1563.e3. 28 indexed citations
13.
Klingspor, Lena, Anna Maria Tortorano, Javier Pemán, et al.. (2014). Invasive Candida infections in surgical patients in intensive care units: a prospective, multicentre survey initiated by the European Confederation of Medical Mycology (ECMM) (2006–2008). Clinical Microbiology and Infection. 21(1). 87.e1–87.e10. 97 indexed citations
14.
Schmalreck, A., Birgit Willinger, V. Czaika, et al.. (2012). Susceptibility Screening of Hyphae-Forming Fungi with a New, Easy, and Fast Inoculum Preparation Method. Mycopathologia. 174(5-6). 467–474. 7 indexed citations
15.
Paulitsch‐Fuchs, Astrid H., et al.. (2009). In-vivoCandida biofilms in scanning electron microscopy. Medical Mycology. 47(7). 690–696. 22 indexed citations
16.
Willinger, Birgit, et al.. (2005). Comparison of a New Commercial Test, GLABRATA RTT, with a Dipstick Test for Rapid Identification of Candida glabrata. Journal of Clinical Microbiology. 43(1). 499–501. 10 indexed citations
17.
Makristathis, Athanasios, et al.. (2005). In vitro activity of fosfomycin alone and in combination with amoxicillin, clarithromycin and metronidazole against Helicobacter pylori compared with combined clarithromycin and metronidazole. European Journal of Clinical Microbiology & Infectious Diseases. 24(4). 276–279. 8 indexed citations
18.
Freydière, A. M., John D. Perry, O. Faure, et al.. (2004). Routine Use of a Commercial Test, GLABRATA RTT, for Rapid Identification of Candida glabrata in Six Laboratories. Journal of Clinical Microbiology. 42(10). 4870–4872. 14 indexed citations
19.
Apfalter, Petra, Jens Boman, Marion Nehr, et al.. (2001). Application of Blood-Based Polymerase Chain Reaction for Detection of Chlamydia pneumoniae in Acute Respiratory Tract Infections. European Journal of Clinical Microbiology & Infectious Diseases. 20(8). 584–586. 12 indexed citations
20.
Willinger, Birgit, J. Beck‐Mannagetta, Alexander M. Hirschl, Athanasios Makristathis, & M. Rotter. (1996). Wirkung von Zinkoxid auf Aspergillus‐Arten: Eine mögliche Ursache der lokalen nichtinvasiven Kieferhöhlen‐Aspergillose. Mycoses. 39(s1). 20–25. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Charalampos Antachopoulos Breakdown of academic impact, for papers by Françoise Botterel Breakdown of academic impact, for papers by Alain Bonnin Breakdown of academic impact, for papers by Silke Schelenz Breakdown of academic impact, for papers by R. Grillot Breakdown of academic impact, for papers by Robert W. Bradsher Breakdown of academic impact, for papers by Thomas M. Kerkering Breakdown of academic impact, for papers by Marie‐Elisabeth Bougnoux Breakdown of academic impact, for papers by Michél Laverdière Breakdown of academic impact, for papers by Dionysios Neofytos
Rankless by CCL
2026